By Dominic Tyer (European Pharmaceutical Review)2025-09-22T13:55:33
The CHMP hands the cancer drug two new recommendations, and the FDA approves its subcutaneous use as Keytruda Qlex.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-29T10:14:00Z
2026-04-30T10:37:00
Sponsored by Shimadzu
2026-03-27T15:37:00
Sponsored by IMA Pharma
2025-10-08T07:00:00
Sponsored by Entegris
2025-07-25T08:10:00
Sponsored by JRS Pharma and Gattefosse, By European Pharmaceutical Review
2025-09-17T08:00:00
Sponsored by Mastercontrol
2026-06-30T14:00:00 2026-06-30T15:00:00
Sponsored by BioRad
Site powered by Webvision Cloud